Delphi Ventures is a venture capital firm specializing in early-stage investments in the healthcare sector, particularly in biotechnology and medical device companies. Founded in 1993, the firm has a history of supporting innovative companies that aim to improve patient care and outcomes. Their investment philosophy focuses on identifying and nurturing companies with strong scientific foundations and promising market potential.

Notable achievements include successful exits through IPOs and acquisitions, contributing to advancements in medical treatments and technologies. Delphi Ventures typically invests in companies developing novel therapeutics, diagnostics, and medical devices, with a keen interest in areas such as oncology, cardiology, and neurology. The firm's key differentiators include a deep understanding of the healthcare industry, a network of experienced advisors, and a collaborative approach with portfolio companies to drive growth and success.

Geographic focus is primarily in the United States, with a particular emphasis on the West Coast. The firm maintains an active presence in the biotech community, participating in industry conferences and events to stay at the forefront of emerging trends.